Minerva Neurosciences
NERV
NERV
76 hedge funds and large institutions have $70M invested in Minerva Neurosciences in 2020 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 30 increasing their positions, 20 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
76
Holders Change
–
Holders Change %
0%
% of All Funds
1.35%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
30
Reduced
20
Closed
11
Calls
$387K
Puts
$352K
Net Calls
+$35K
Net Calls Change
+$374K
Top Buyers
| 1 |
Morgan Stanley
New York
|
+$1.12M |
| 2 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$906K |
| 3 |
Millennium Management
New York
|
+$763K |
| 4 |
Two Sigma Advisers
New York
|
+$548K |
| 5 |
Two Sigma Investments
New York
|
+$542K |
Top Sellers
| 1 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$2.44M |
| 2 |
AG
Artal Group
Luxembourg
|
-$2.42M |
| 3 |
NLVP
New Leaf Venture Partners
New York
|
-$1.43M |
| 4 |
FM
Frazier Management
Seattle,
Washington
|
-$1.14M |
| 5 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$666K |
